🦊/Investors

Innovation Works β€” 2021 Investments

3 investments dated 2021 Β· listed companies and verified rows first Β· show all

Duo Oncologyduooncology.comin𝕏Feb 2021βœ“ verified

Duo Oncology is a clinical-stage company developing tumor-activated prodrug combinations intended to replace toxic multi-agent chemotherapy with single medicines that concentrate activity in tumors.

BiotechHealthtechPittsburgh, US

SONG LI(Director, Promoter)JING-ZHOU HOU(Executive Officer, Director, Promoter)Sam Rothstein(CEO & Cofounder)inKatherine Eichinger(Chief Operating Officer)STEPHEN THORNE(Executive Officer, Promoter)in

BoardJOE GATTO(Director)in

Co-investorsUlu VenturesNuFund Venture GroupNuFund

Honeycomb Credithoneycombcredit.comin𝕏Seed Β· Mar 2021 Β· $2M

Honeycomb Credit runs an investment crowdfunding platform where individuals can invest in local small businesses, such as breweries, restaurants, and shops, in exchange for potential returns.

FintechImpact & Social GoodMarketplacesPittsburgh, US

George Cook(Co-founder & CEO)inKen Martin(Founder)inMathias Jamora(CFO)inChristian Bilger(Executive Officer)Edward Engler(Director)

Co-investorsAmerican Family Insurance Institute for Corporate and Social ImpactCitta CapitalDelaware Crossing Investor GroupMudita VentureSustainVCSymphonic Capital+2 more

Rimsysrimsys.ioin𝕏Dec 2021 Β· $16M

Rimsys provides regulatory information management software that centralizes product registrations, submissions, compliance tracking, and change management for medical device manufacturers operating globally.

Enterprise SoftwareHealthtechMedical DevicesSaaSPittsburgh, US

Brad Ryba(CSO and Co-Founder)inJames Gianoutsos(Founder and CEO)in

BoardAndrew Hedin(Director)inJohn McIlwraith(Director)inEric Boduch(Director)in

Co-investorsAllos VenturesBessemer Venture PartnersRiverfront Ventures, LLC

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.